Calcutta High Court backs Reliance Infra with ₹780 crore arbitration ruling against Damodar Valley Corp

The dispute began in April 2017 when Reliance Infrastructure sought arbitration over DVC’s delays in awarding the engineering contract.

The dispute began in April 2017 when Reliance Infrastructure sought arbitration over DVC’s delays in awarding the engineering contract.

The Indian equity markets have been on a roll and there seems to be no stopping the bull run, with money continuing to flow in predominantly from domestic sources. But is that reason enough to buy in?

The latest fund raise was part of $10 billion global medium-term programme of the company. The proceeds will be used to finance eligible green projects.

The scope of the inspection included one Drug Substance and one Drug Product manufacturing unit, a Medical Device Assembly unit, an Analytical Quality Control Laboratory, two Microbiological Control Laboratories, and two Warehouses.

Tata Motors Share Price | The Tata Motors Group intends to invest 9,000 crore in the greenfield manufacturing facility, which has been designed for an annual production capacity of over 250,000 vehicles. The production will begin in a phased manner…

Biocon has not disclosed the specifics of the observations, but in an exchange filing, the company said that it would address the cited observations within the stipulated time. “The Company does not foresee any impact on the business,” Biocon said.

Reliance Industries Share Price | The transfer of non-news and current affairs TV channels held by Viacom18 to Star India is subject to conditions laid by the Competition Commission of India, the company informed the exchanges.

In an exclusive interview with CNBC-TV18, Jamie Dimon, Chairman and CEO of JPMorgan Chase & Co, mentioned that the US has become too reliant on China for essential resources like rare earths, semiconductors, and pharmaceutical ingredients. He emphasized that this…

Lupin Share Price | The USFDA inspected the facility from September 16 to September 27. The pharma company said it is addressing the observations comprehensively and will respond to the US drug regulator within the stipulated timeframe.

Of the total shares offloaded, Global Capital Group-owned SmallCap World Fund acquired a 3.3% stake for ₹788 crore, according to bulk deal data available on the BSE.